Synergy Pharmaceuticals has appointed Marino Garcia to the newly-created role of senior VP, corporate development.
Garcia joins the New York-based gastrointestinal specialist from Aptalis Pharma, which also focused on the gastrointestinal market, as well as cystic fibrosis.
This experience will be beneficial as Garcia looks to play a significant role in Synergy’s strategic corporate planning and business development activities as it moves several products to late-stage development.
“I am excited to be joining Synergy,” said Garcia. “This company has quickly transitioned from a small biotech start-up to a late-stage drug development company with major clinical milestones in the near term.”
Prior to his time at Aptalis Garcia was VP of US commercial operations and new product development at Aspreva Pharmaceuticals. He also has experience at Lilly and Pfizer.